Both in Pharmaceuticals
Soligenix vs Vistagen Therapeutics
Over the past year SNGX returned −76.6% and VTGN returned −95.7%; their daily moves had a correlation of 0.10.
SNGX −76.6% VTGN −95.7%Growth of $1, one year, split-adjusted
| Metric | SNGX | VTGN |
|---|---|---|
| Price | $0.3678 | $0.1706 |
| Market cap | $8.0M | $7.6M |
| Today | −1.95% | +0.38% |
| 1 month | +1.6% | −44.6% |
| 6 months | +6.6% | −72.2% |
| Year to date | −72.6% | −74.2% |
| 1 year | −76.4% | −95.8% |
| Revenue growth (YoY) | — | +504.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −882.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.0× |
| Net cash | $9.8M | $31.7M |
| Dividend yield | — | — |
| Volatility (60d) | 41.4% | 106.8% |
| Short % of float | 0.8% | 5.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).